Skip to content
UT MD Anderson· @UTMDAnderson · X·· 2026-04-20Score60
Body · original

Can a genetically engineered tumor-infiltrating lymphocyte demonstrate effectiveness in melanoma?

Dr. Rodabe Amaria shared results of a Phase 1 study of KSQ-001EX in patients with select advanced solid tumors:
http://
spr.ly/6010B6Clbu #AACR26 #EndCancer

Heat 18 · 11 likes · 2 replies · 5 reposts

Source: UT MD Anderson · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org